These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 32015340)

  • 1. Autophagy in metabolic syndrome: breaking the wheel by targeting the renin-angiotensin system.
    Menikdiwela KR; Ramalingam L; Rasha F; Wang S; Dufour JM; Kalupahana NS; Sunahara KKS; Martins JO; Moustaid-Moussa N
    Cell Death Dis; 2020 Feb; 11(2):87. PubMed ID: 32015340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.
    Frigolet ME; Torres N; Tovar AR
    J Nutr Biochem; 2013 Dec; 24(12):2003-15. PubMed ID: 24120291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms.
    Kalupahana NS; Moustaid-Moussa N
    Crit Rev Biochem Mol Biol; 2012; 47(4):379-90. PubMed ID: 22720713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the metabolic syndrome: the emerging role of aquaglyceroporins.
    da Silva IV; Rodrigues JS; Rebelo I; Miranda JPG; Soveral G
    Cell Mol Life Sci; 2018 Jun; 75(11):1973-1988. PubMed ID: 29464285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on the Potential Benefits of Antihypertensive Peptides towards Metabolic Syndrome.
    Jahandideh F; Wu J
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.
    Putnam K; Shoemaker R; Yiannikouris F; Cassis LA
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1219-30. PubMed ID: 22227126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and Functions of the Renin-Angiotensin System in White and Brown Adipose Tissue.
    Pahlavani M; Kalupahana NS; Ramalingam L; Moustaid-Moussa N
    Compr Physiol; 2017 Sep; 7(4):1137-1150. PubMed ID: 28915321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance.
    Kalupahana NS; Moustaid-Moussa N
    Obes Rev; 2012 Feb; 13(2):136-49. PubMed ID: 22034852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis.
    Li ZL; Woollard JR; Ebrahimi B; Crane JA; Jordan KL; Lerman A; Wang SM; Lerman LO
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1132-41. PubMed ID: 22383702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin system in the pathophysiology of type 2 diabetes.
    Goossens GH
    Obes Facts; 2012; 5(4):611-24. PubMed ID: 22986649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy as a crosstalk mediator of metabolic organs in regulation of energy metabolism.
    Kim KH; Lee MS
    Rev Endocr Metab Disord; 2014 Mar; 15(1):11-20. PubMed ID: 24085381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative renin-angiotensin system pathways in adipose tissue and their role in the pathogenesis of obesity.
    Slamkova M; Zorad S; Krskova K
    Endocr Regul; 2016 Oct; 50(4):229-240. PubMed ID: 27941178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance.
    Ramalingam L; Menikdiwela K; LeMieux M; Dufour JM; Kaur G; Kalupahana N; Moustaid-Moussa N
    Biochim Biophys Acta Mol Basis Dis; 2017 May; 1863(5):1106-1114. PubMed ID: 27497523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant Effects of Oral Ang-(1-7) Restore Insulin Pathway and RAS Components Ameliorating Cardiometabolic Disturbances in Rats.
    Figueiredo VP; Barbosa MA; de Castro UGM; Zacarias AC; Bezerra FS; de Sá RG; de Lima WG; Dos Santos RAS; Alzamora AC
    Oxid Med Cell Longev; 2019; 2019():5868935. PubMed ID: 31396301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrient excess and autophagic deficiency: explaining metabolic diseases in obesity.
    van Niekerk G; du Toit A; Loos B; Engelbrecht AM
    Metabolism; 2018 May; 82():14-21. PubMed ID: 29289514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy, Metabolic Disease, and Pathogenesis of Heart Dysfunction.
    Wang F; Jia J; Rodrigues B
    Can J Cardiol; 2017 Jul; 33(7):850-859. PubMed ID: 28389131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adipose tissue renin-angiotensin system in obese].
    Yasue S; Ebihara K; Nakao K
    Nihon Rinsho; 2012 Sep; 70(9):1550-5. PubMed ID: 23012802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity.
    Yvan-Charvet L; Quignard-Boulangé A
    Kidney Int; 2011 Jan; 79(2):162-8. PubMed ID: 20944545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of metabolic syndrome on osteoarthritic joints.
    Dickson BM; Roelofs AJ; Rochford JJ; Wilson HM; De Bari C
    Arthritis Res Ther; 2019 Dec; 21(1):289. PubMed ID: 31842972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic syndrome.
    Zhao J; Duan L; Li J; Yao C; Wang G; Mi J; Yu Y; Ding L; Zhao Y; Yan G; Li J; Zhao Z; Wang X; Li M
    Biomed Pharmacother; 2024 Jul; 176():116807. PubMed ID: 38795644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.